Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Hemp Health One Debuts Its Single-Use CBD Vape Pen and Is Offering a Free Giveaway


VIP LAUNCH PROMO! TRY OUT REMEDY FOR FREE FOR A LIMITED TIME!

Hemp Health One announces the launch of a new product today — its CBD vape pen*. The hemp-based vape formula contains full-spectrum CBD oil with terpenes from the Remedy CBD hemp strain. Also, it has zero artificial flavors, cutting agents, or additives. And there’s less than 0.3% THC, in accordance with U.S. federal regulations.

To celebrate the release of this product, Hemp Health One is giving away 100 pens for free. They’re available on the company’s website with a maximum of 1 per customer. To take advantage of this special offer, add one to your cart and then simply pay a small shipping fee of $5.

Take Advantage here: http://www.hemphealthone.com/products/remedy-single-use-cbd-vape-pen

Each vape pen comes fully charged and is meant for one-time use only. So, after the very last puff from the pen, it’s okay to toss it out and replace it with another one. In total, the pen has 250mg of CBD which derives from non-GMO hemp grown on sustainable farms in Colorado.

In addition, the product’s manufactured in the United States and is intended for individuals 21 years and older. The vape oil formula gets fully tested by an independent third-party lab, and the results show it’s free of pesticides and solvents.

Finally, this product fits in perfectly with active lifestyles because it provides a fast-acting, on-the-go dose of CBD. After taking a few inhales from the pen, the effects of the CBD and Remedy terpenes kick in within minutes.

If you want to learn more about Hemp Health One or its other products, visit the company’s website at http://www.hemphealthone.com. Also, discover fresh information about CBD by reading some articles on their blog page at http://www.hemphealthone.com/blogs/the-hemp-health-one-blog

To get in touch with the company send an email to support@hemphealthone.com or give them a call at 1-888-502-0015.

Share article on social media or email:

The Journal of Pain Research, a Dove Press Publication, Becomes Official American Society of Pain & Neuroscience Journal


Taylor & Francis Logo

I am incredibly excited that the Journal of Pain Research has become the official journal of The American Society of Pain and Neuroscience.

An affiliation agreement between the Journal of Pain Research and one of fastest-growing medical societies, the American Society of Pain & Neuroscience, has recently been agreed.

An international, peer-reviewed, open access, online journal that publishes laboratory and clinical findings in the fields of pain research and the prevention and management of pain, the Journal of Pain Research will now become the official publication for The American Society of Pain and Neuroscience (ASPN).

The society is dedicated to advancement in the fields of Pain and Neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation.

Therefore, Co-Founder and President of ASPN, Dawood Sayed M.D stated that he was delighted with the new agreement, which represents a perfect partnership.

“I am incredibly excited that the Journal of Pain Research has become the official journal of ASPN,” said Dawood, who created the society in 2018 alongside Dr Tim Deer.

“One of the guiding principles of ASPN is to improve the field with quality science and evidence. Partnering with JPR and publishing science in an open access platform for widespread dissemination is vital to our mission statement.”

A Dove Press publication, the Journal of Pain Research will continue to publish high-quality, peer-reviewed original research, reviews, symposium reports, hypothesis formation and commentaries are all considered for publication.

And Dawood added that the quality of articles published under the directorship of Editor-in-Chief, Michael Schatman, was why this journal, in particular, was chosen to represent ASPN.

“The impact of the Journal of Pain Research in our field under Michael Schatman has been exceptional. I look forward to continuing the forward progress of the journal as an Associate Editor in Chief and establishing it as the premier journal in the field of pain and neuroscience,” he added.

Dr Schatman, a clinical psychologist who has spent the past 30 years working in multidisciplinary chronic pain management, said: “I’m excited by the affiliation of ASPN, as their membership includes many of the top pain scientists in the world. Their desire to publish much of their work in the Journal of Pain Research will result in further advancement of the overall quality of the journal.”

Todd Hummel, Taylor & Francis Global Publishing Director Medicine, adds: “This is a great opportunity for the Journal of Pain Research and we’re exciting for the future partnership between ourselves and ASPN.”

Notes

The American Society of Pain and Neuroscience is ASPN is committed to achieving its goals by embracing diversity that is inclusive to individuals of all genders, cultures, age, race, sexual orientation, and profession.

About Dove Medical Press

Dove Medical Press Ltd is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC.

We specialize in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.

Dove Medical Press was founded in 2003 with the objective of combining the highest editorial standards with the ‘best of breed’ new publishing technologies. We have offices in Manchester and London in the United Kingdom, representatives in Princeton, New Jersey in the United States, and our editorial offices are in Auckland, New Zealand.

Share article on social media or email:

SIUE’s Alison Reeves Named SEHHB Interim Associate Dean


SEHHB Interim Associate Dean Alison Reeves, PhD.

“In the SEHHB, we will be adding several high-quality online options, developing new programs and strengthening partnerships with K-12 schools in the region.”

Southern Illinois University Edwardsville School of Education, Health and Human Behavior (SEHHB) Dean Robin Hughes, PhD, has named Alison Reeves, PhD, as interim associate dean. Reeves assumed the leadership role in September and will serve a two-year term.

“As interim associate dean, Dr. Reeves will help support faculty development, the East St. Louis Charter High School (CHS), as well as innovation and program development,” Hughes said. “While Associate Dean Paul Rose and I have certainly worked to support these areas, we know that more focused attention is needed. Dr. Reeves is the perfect fit for the role. Her skillset, knowledge and leadership are highly sought. The SEHHB will gain better footing in the educational landscape, as we benefit from her expertise.”

Hughes emphasizes Reeves’ experience as a public school leader, work with Charters, including service as a Charter school board president, and service as chair of the SEHHB Department of Educational Leadership where she has taken the lead in innovation with organizations that will help move the school forward in program development and online presence.

“Dean Hughes is a visionary leader for the School of Education, Health and Human Behavior, and I’m enthusiastic about joining her leadership team,” Reeves said. “The SEHHB has incredible faculty, and this position gives me a chance to support them in their work.”

Reeves’ responsibilities include leading:

  • Educator preparation and licensure processes, such as coordinating SEHHB compliance with state and accreditor rules
  • Development of new programs, including online and entrepreneurial programs
  • Assessment processes that ensure the quality of our academic programs
  • Recruitment and retention efforts that contribute to a diverse workforce
  • Technical support for the CHS

“My passion is building high-quality programs that promote educational equity and social justice whether it is in a K-12 setting or at the University level,” Reeves explained. “Most of my new job responsibilities require building teams and coordinating their efforts in a sustained way. In my 20-plus years of experience as a K-12 administrator, program director for our educational administration program and chair of the Department of Educational Leadership, I have had multiple opportunities to build and implement innovative academic programs.”

“In the SEHHB, we will be adding several high-quality online options, developing new programs and strengthening partnerships with K-12 schools in the region,” she added. “Our focus will be on recruiting diverse cohorts of students in all majors in the SEHHB and enhancing practices that support retention.”

The SIUE School of Education, Health and Human Behavior prepares students in a wide range of fields including public health, exercise science, nutrition, instructional technology, psychology, speech-language pathology and audiology, educational administration, and teaching. Faculty members engage in leading-edge research, which enhances teaching and enriches the educational experience. The School supports the community through on-campus clinics, outreach to children and families, and a focused commitment to enhancing individual lives across the region.

Share article on social media or email:

Treatment for substance use disorder works, just ask John Brooks Recovery Center


News Image

John Brooks Recovery Center opens new state-of-the-art residential treatment facility in Mays Landing.

“This is an exciting time in the life of John Brooks Recovery Center as we open our new state-of-the-art residential treatment facility,” said Michael Santillo, CEO of JBRC.

To the single mom who has been trying to get clean for years, there is a way. To the person down the street who is broken and feels hopeless, help is available. To the stressed alcoholic with a history of mental health issues, recovery is possible. To the person struggling with substance use disorder behind closed doors, hope is here – and it’s found at John Brooks Recovery Center (JBRC).

It’s been over 50 years since JBRC first opened its doors. It all started in 1969 when John Brooks, an Atlantic City resident, former addict and ex-con realized that if he stopped using drugs, he’d stop going to prison. Shortly thereafter, Brooks was brave enough to share his story and eventually open a small storefront outpatient program dedicated to helping individuals with substance use disorders. The nonprofit was quickly accepted by the community and has since evolved through the years as it continues to grow exponentially.

JBRC provides a host of treatment options that attest to its success, as well as two recovery community centers, a recovery housing program and physical health. This month, the nonprofit opened the doors to its new residential treatment facility in Mays Landing that expands its current continuum of care and allows the organization to serve even more people. In conjunction with the opening, JBRC also unveiled a refreshed brand identity and was also named #1 Gold Drug and Alcohol Recovery Program by Best of the Press 2020.

Throughout all its endeavors and accolades, JBRC has remained focused on one thing – to help individuals who are struggling with substance use disorder to achieve recovery – regardless of their financial circumstance. “This is an exciting time in the life of John Brooks Recovery Center as we open our new state-of-the-art residential treatment facility,” said Michael Santillo, CEO of JBRC. “In conjunction with this grand opening, we felt it was so important for us to have an enhanced brand identity and properly positioned mission that will help us better serve the community.”

John Brooks Recovery Center’s refreshed mission is to provide the highest quality, evidence-based treatment services to help individuals overcome substance use disorders regardless of financial circumstance or socio-economic background. The nonprofit’s enhanced logo is a natural evolution of the original John Brooks logo and further builds on its unparalleled continuum of care, specializing in recovery, hope and healing. These three words are also symbolized through the light blue trifecta icon, which appears in specific circular logo variations highlighting the nonprofit’s 50 years of dedicated service.

JBRC’s new $18M Mays Landing residential treatment facility offers a recovery-oriented model that integrates physical health, behavioral health and recovery support services. This new facility offers 46 short-term beds, 46 long-term beds and 23 detox beds, and will expand its current continuum of care, allowing the organization to help even more people overcome substance use disorders.

“Our programs are clinically driven with a length of stay from 3-6 months for long-term residential and consist of individual, group and family counseling, psychoeducation classes, medication assisted treatment, recreation, psychiatric services, medical services and education services,” Santillo said.

A 55-year-old JBRC client attests to the nonprofit’s success in her own life. “Here at John Brooks, the counselors showed me how to identify my character defects and deal with them, as well as look for my triggers and have a plan to prevent relapse,” she says. “The meetings have made me comfortable with my Higher Power and understanding how to work the 12 steps. If I didn’t come to JBRC, alcohol would have likely killed me. But being here has taught me how to live.”

JBRC’s new residential treatment facility, located at 1455 Pinewood Boulevard in Mays Landing, is now accepting new patients and referrals. To learn more, call 609-345-2020.

About John Brooks Recovery Center

Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include: Residential, Outpatient, Medication Assisted Recovery and Inmate Re-entry. To learn more, visit jbrcnj.org or call 609-345-2020.

Share article on social media or email:

Career Partners International Launches PowerAmp™ Coaching – Industry Leading Professional Development Solution


“In my nearly 30 years of Human Resources and Learning & Development I have not seen a coaching program so rooted in sound science,” Bill Kellner, CEO of Career Partners International.

Career Partners International (CPI) is pleased to announce the launch of PowerAmp™ Coaching, the world’s first professional development coaching program delivered by trained coaches with scientifically created artificial intelligence. This combination of professional coaching amplified by technology gives organizations the power to provide coaching at a fraction of traditional costs while minimizing risk.

CPI has launched this program in conjunction with LeaderAmp, founded by Dr. Matt Barney, Organizational Psychologist. In Dr. Barney’s previous work as the head of learning and development in major organizations around the globe he identified three key obstacles to successful coaching engagements. First was the inability to view and measure progress in real time. Second was the difficulty in predetermining which participants would succeed in coaching. Third was the limitation of coaching to those only at the highest levels of major corporations.

PowerAmp Coaching combines the expertise of proven coaches with the tracking and guidance of custom built and validated artificial intelligence. This unique solution starts by identifying those in the organization who will most benefit from coaching then quickly identifies areas for improvement based on proprietary, peer reviewed and validated assessments. With these highly accurate and precise tools, organizations and coaches can see which participants are on track and which need more support. By partnering with AI and utilizing consolidated project management tools, coaches provide greater levels of support to more participants, opening the possibility of coaching to more employees than ever before.

“In my nearly 30 years of Human Resources and Learning & Development I have not seen a coaching program so rooted in sound science. Coupling CPI’s coaching capabilities with LeaderAmp’s scientific approach and participant guidance brings previously unheard-of possibilities to the world of Professional Development,” states Bill Kellner, CEO of Career Partners International.

With over 50 Member Firms and 300 locations around the globe CPI is uniquely positioned to deliver coaching to national, multi-national, and international organizations with a proven and uniform approach. PowerAmp Coaching combines this coaching presence with scientifically sound and proven technology to deliver measurable results to employees at all levels and in all corners of the world. PowerAmp Coaching solves what have historically been the most difficult employee development problems faced by virtually all organizations.

About Career Partners International LLC.

Career Partners International was founded in 1987 and is one of the largest consultancies in the world. With over 300 offices in over 50 countries, Career Partners International is a leading provider of outplacement, career management, executive coaching, and leadership development services to clients and their employees worldwide.

Share article on social media or email:

Hope Biosciences Stem Cell Research Foundation Selects Phlexglobal to Support Rapid, Compliant Investigational New Drug Application for COVID-19 Therapy


We found the right partner in Phlexglobal Donna Chang Founder, Hope Biosciences Stem Cell Research Foundation

Phlexglobal, a leading innovative technology and services provider for the life sciences industry, today announces that Hope Biosciences Stem Cell Research Foundation has selected Phlexglobal’s advanced SaaS solution, PhlexSubmission, to enhance the efficiency and quality of its eCTD submissions process. As an organization dedicated to advancing research through innovative protocols using the latest technology, the Foundation was looking for the most advanced Electronic Common Technical Document (eCTD) software partner to support its mission. PhlexSubmission – a robust, highly configurable, and easy-to-use publishing engine for electronic submissions such as eCTD, NeeS, and VNeeS – was the clear winner.

“We launched the Foundation this year to accelerate translational research in regenerative medicine so that therapies could be delivered to patients faster, ultimately by delivering high-quality data for quicker approval,” noted Donna Chang, Founder, Hope Biosciences Stem Cell Research Foundation. “With three COVID-19 protocols already approved, our team needed a solution provider to match our dedication to speed and quality, and whose submissions technology could meet our stringent requirements and growing trial portfolio. We found the right partner in Phlexglobal.”

With its previous eCTD software, the Foundation was faced with a costly and cumbersome “pay-per-submission” model, with each new application requiring a new payment through a cumbersome and time-consuming process. In addition, the eCTD software itself was hard to learn and use, adding time and effort – an unnecessary burden when every hour counts.

When Hope Biosciences Stem Cell Research Foundation evaluated solution providers, Phlexglobal’s PhlexSubmission eCTD software stood out in multiple key areas:


  • Efficiency: The Foundation remarked favorably on the highly intuitive and easy-to-use PhlexSubmission user interface (UI) – complete with Phlexglobal’s unique Virtual Electronic Realtime Assistant (VERA) to help guide users at every step.
  • Quality: PhexSubmission software is fully validated and always in compliance with the latest ICH guidelines, with a proven record supporting more than 4000 successful eCTD submissions for 17000 products to the FDA, EMA, and other agencies and supporting virtually every country.
  • Innovation: By leveraging advanced AI and machine learning technologies, PhlexSubmission streamlines the process by including automation running in the background, as well as the ability to automatically read and classify eCTD documents, extract relevant metadata, and auto-generate an eCTD submission.
  • Cost-Effectiveness: PhexSubmission offers organizations unlimited submissions to an unlimited number of countries at a fixed cost – providing budget predictability, and allowing study teams to spend more time on critical trial tasks instead of administration

“Phlexglobal is proud to support the important work being done by Hope Biosciences Stem Cell Research Foundation to speed the development of innovative therapies for COVID-19,” said John McNeill, Chief Executive Officer of Phlexglobal. “The Foundation joins more than 16 other research organizations developing COVID-19 vaccines and treatments which we are actively supporting with world-class regulatory compliance software and expert services. On behalf of the entire Phlexglobal team worldwide, we are honored to play a part in fighting the most difficult health crisis of our lifetimes.”

COVID-19 Support: Phlexglobal Resources to Fast Track Trials and Ensure Business Continuity

If you have any questions regarding the impact of COVID-19 from a clinical or regulatory standpoint, you can submit them to Phlexglobal for a prompt answer. If you need support for your research, Contact Phlexglobal today to receive COVID-19 study help tomorrow.

About Hope Biosciences Stem Cell Research Foundation

Hope Biosciences Stem Cell Research Foundation, administered through the Greater Houston Community Foundation, was founded to address the need to accelerate translational research in regenerative medicine so that therapies could be delivered to patients faster. The foundation is designed to not just support promising trials but to help develop innovative protocols using the latest technology to ultimately deliver high-quality data for quicker approvals. Today, the foundation is leading the effort in using mesenchymal stem cells to combat COVID-19, with three FDA approved protocols for coronavirus. Current active protocols also include Cerebral Palsy, Parkinson’s Disease, Spinal Cord Injury, Traumatic Brain Injury, Alzheimer’s Disease, ALS and Severe Osteoarthritis. For more information, please visit https://www.hopebio.org/.

About Phlexglobal

Phlexglobal is the leading technology and services organization for clinical and regulatory matters with a focus on helping clients to master their digital agenda via proven AI solutions. Phlexglobal combines software and leading expert services to offer a unique solutions portfolio with easy to achieve automation via data generation that lifts organizations to a new level of effectiveness.

PhlexTMF is the company’s Trial Master File software. Regulatory solutions including PhlexSubmission for eCTD and CTD, PhlexIDMP, PhlexEVMPD, and PhlexRIM are considered highly innovative in the industry for out-of-the-box best practices capabilities, automation technology, and user-focused design.

PhlexDistiller, a machine learning platform that reads documents and converts unstructured content into structured data, achieves automation of regulatory and clinical processes and completes the end-to-end solutions offering from Phlexglobal.

Share article on social media or email:

Suicide Survivor Jim Denning Brings Hope During Pandemic with His Book ‘Make it to Midnight’


News Image

“It’s a book for anyone who is struggling mentally and physically in today’s world.”

“I’m still alive,” writes Tammi, an anonymous reviewer on Amazon. After reading, Make It to Midnight: Learning to Live When You Want to Die by best-selling author, Jim Denning, these three words described her feelings of hope. Jim Denning doesn’t know Tammi, but he does know that he has helped another life with his self-help suicide prevention book, which he wrote after he battled with suicidal thoughts years before.

In 2009, Jim Denning was dead mentally and, on the verge, physically. While maintaining a seemingly normal life, with no external “reason” to be depressed, he still found himself with depression, anxiety, and at one point had a gun in his hand. However, through his faith in God and his own self-determination, Jim Denning essentially hacked his mind and re-wired his spirit. He chose life above all else, which inspired him to write the book.

Founder of The Denning Center in San Antonio, Texas, Jim specializes in Accelerated Resolution Therapy. He named his 501(c)3 nonprofit the same title of the book, Make It to Midnight, which is committed to providing necessary suicide prevention tools and resources. Jim Denning has helped folks suffering from suicidal thoughts across the nation for years. Now, he hopes to reach even further by sharing his story available in multiple formats.

In the book, he describes critical protocols that have helped many of his patients overcome trauma, suicidal thoughts and negative feelings associated with everyday life. The book offers both help and hope to those who struggle with mental illness and want to live a healthier, happier, and more fulfilled life.

“It’s a book for anyone who is struggling mentally and physically in today’s world,” said Jim Denning. “Many go through life thinking that the enormous weight they feel is normal, and as a society, we need to learn how to shed the pain effectively.”

According to the Centers for Disease Control and Prevention, since the start of the pandemic, symptoms of anxiety and depressive disorders have increased considerably in the U.S., especially from April to June, compared to 2019. Over 40 percent reported experiencing higher levels of anxiety and a significant number of respondents reported “having seriously considered suicide…” with self-reported unpaid caregivers for adults increasing nearly 31 percent and essential workers increasing over 20 percent.

“After suffering from depression, myself, I want to be able to reach as many people as I can,” said Jim Denning, “Suicide rates have increased in 2020 so the release of the audio book couldn’t be timelier.”

While some of the ideas stem from scripture, others are backed by science, offering a solid foundation for readers to build upon. One reviewer commented, “Even if you are not religious, the scripture references complement the message the author is trying to convey.”

To purchase a paperback or Kindle version of Make it to Midnight, visit amazon.com. The audio book of Make it to Midnight: Learning to Live When you Want to Die is scheduled to release by the end of the year.

Jim Denning, author of Make It to Midnight: Learning to Live When You Want to Die, is a licensed professional counselor and pastor living in San Antonio. With his Master of Arts degree in counseling and ministry, Denning uses his own experiences to relate to clients and help them combat their own situation.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Bay Area


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Bay Area, CA for 2021. The informational guide recognizes the top 13 rehab facilities based on cost, treatment options, location, accompanying services, and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Bay Area, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Bay Area with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Bay Area. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Bay Area, CA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-bay-area-ca

2021 Best Rehab Facilities in Bay Area, CA (in alphabetical order)

New Life Recovery Centers

782 Park Avenue, Suite 1

San Jose, CA 95126

408-297-1182

Ohlhoff Recovery Programs

601 Steiner Street

San Francisco, CA 94117

415-621-4388

Wellness Retreat Recovery

10615 Crothers Road

San Jose, CA 95127

855-762-3797

New Start Recovery Solutions

2449 Pacheco Street

Concord CA 94520

866-303-6275

Harm Reduction Therapy Center

45 Franklin Street, Suite 320

San Francisco, CA 94102

415-863-4282

New Bridge Foundation

2323 Hearst Avenue

Berkeley, CA 94709

866-772-8491

Support Systems Homes in San Jose

1202 Meridian Avenue

San Jose, CA 95125

408-370-9688

Bayside Marin Treatment Center

718 4th Street

San Rafael, CA 94901

844-596-6350

Olympia House Rehab

11207 Valley Ford Road

Petaluma, CA 94952

888-795-1965

Alta Mira Recovery Programs

125 Bulkley Avenue

Sausalito, CA 94965

888-292-7802

Bay Addiction Detox Center

1838 El Camino Real #100

Burlingame, CA 94010

866-530-5486

Friendship House Association of American Indian

56 Julian Avenue

San Francisco, CA 94103

415-865-0964

Serenity Knolls Treatment Center

145 Tamal Road

Forest Knolls, CA 94933

855-969-8838

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Palm Springs


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Palm Springs, CA for 2020. The informational guide recognizes the top 13 rehab facilities based on cost, treatment options, location, accompanying services, and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Palm Springs, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Palm Springs with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Palm Springs. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Palm Springs, CA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-palm-springs-ca

2020 Best Rehab Facilities in Palm Springs, CA (in alphabetical order)

ABC Recovery Center

44374 Palm Street

Indio, CA 92201

760-342-6616

Addiction Therapeutic Services

One Mirage Place 69730 Highway 111, Suite 109

Rancho Mirage, CA 92270

760-322-1777

Awareness Program

1445 North Sunrise Way #103

Palm Springs, CA 92262

760-342-1233

Bella Monte Recovery Center

68111 Calle Las Tiendas

Desert Hot Springs, CA 92240

800-974-1938

Blue Tiger Recovery

4375 E Calle De Ricardo, Ste B

Palm Springs, CA 92264

877-867-6768 ; 760-534-3487

California Behavioral Health

37066 Bankside Drive

Cathedral City, CA 92234

855-404-2172

Ken Seeley Rehab Center

1900 East Tahquitz Canyon Way, Suite B1

Palm Springs, CA 92262

855-945-1289

Kiloby Center for Recovery

71777 San Jacinto Drive, Suite 102

Rancho Mirage, California 92270

833-200-6929

Life Springs Recovery Services

490 South Farrell Drive

Palm Springs, CA 92262

800-746-0937

Michael’s House Treatment Center

1910 South Camino Real

Palm Springs, CA 92262

844-675-0976

Palm Springs Sober Life

500 West Racquet Club Road

Palm Springs, CA 92262

760-482-8144

Ranch Recovery Centers, Inc

7885 Annandale Avenue Desert

Hot Springs, CA 92240

760-251-5703

Soroptimist House of Hope

13525 Cielo Azul Way

Desert Hot Springs, CA

760-329-4673

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

2019 Virtual Workshop Dec. 1, 2020


WCG FDAnews

WCG FDAnews

Medical Device Risk Management:

Implementing ISO 14971:2019

A Virtual Workshop Presented by FDAnews and Ombu Enterprises

Tuesday, Dec. 1, 2020, 10:00 a.m. – 4:30 p.m. EST

https://www.fdanews.com/mdriskmanagement

ISO 14971:2019 is changing the standards around risk management — and the introduction of the EU-MDR is only making things more complicated. This process has never been simple but having to adjust clause numbers, documentation and risk-management systems while successfully merging the two new sets of expectations adds extra challenges.

How does one prepare for these changes? Has the team worked on risk analysis and evaluation? Are the risk management files and plans up-to-date?

This Medical Device Risk Management virtual workshop on Dec. 1 will cover everything needed to implement an efficient and effective risk management system. Through expert advice, attendees will gain a basic understanding of medical device regulations, discover how ISO 14971:2019 will impact procedures and work to identify gaps in implementation plans.

The risk management guide is Dan O’Leary, a favorite presenter at dozens of FDAnews-sponsored workshops. Dan will share tips on how to define acceptable risk, create a risk management plan, and complete an overall residual risk evaluation. He’ll also share how these requirements connect to the EU-MDR and what organizations need to do to match the two standards.

During this virtual workshop, attendees will cover:


  • Basic medical device regulations and standards
  • Risk management files and plans
  • Acceptable risk definitions and the risk matrix
  • Risk analysis, evaluation and control
  • Residual risk evaluation
  • Risk management review
  • Production and post-production requirements
  • EU-MDR adjustments and expectations
  • ISO 14971:2019 implementation and process standards
  • Annex I risk-specific requirements

Implementing ISO-14971:2019 will require a careful look at one’s current risk management systems and a deep understanding of where they need to go. This virtual workshop can make that process simpler and more successful.

Want to share this experience with your colleagues?

Ask us about our tiered discounts for multiple participants!

Virtual Workshop Details:

Medical Device Risk Management:

Implementing ISO 14971:2019

A Virtual Workshop Presented by FDAnews and Ombu Enterprises

Tuesday, Dec. 1, 2020, 10:00 a.m. – 4:30 p.m. EST

https://www.fdanews.com/mdriskmanagement

Tuition:

$597 per site

Easy Ways to Register:

Online: https://www.fdanews.com/mdriskmanagement

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email: